Publicado 06/11/2014 14:02
- Comunicado -

Eisai Continues Global Expansion with New Office in Melbourne, Australia (y 2)

Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides," which we call our human health care (hhc) philosophy. With over 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realise our hhc philosophy by delivering innovative products in various therapeutic areas with high unmet medical needs, including Oncology and Neurology.

As a global pharmaceutical company, our mission extends to patients around the world through our investment and participation in partnership-based initiatives to improve access to medicines in developing and emerging countries.

For more information about Eisai Co., Ltd., please visit http://www.eisai.com

About the HAYABUSA Plan

The "HAYABUSA" plan was named after the Japanese asteroid probe, the Hayabusa, and embodies the spirit of Eisai employees who aim to overcome whatever challenges they may face to achieve the objectives of a given plan, in the same way that the asteroid probe overcame major crises such as engine trouble and communication blackouts and returned safely to Earth after traveling over six billion km in seven years.

References

1. Breast cancer care WA. Statistics. Available at: http://www.breastcancer.org.au/about-breast-cancer/statistic... . Accessed: October 2014.

2. Halaven Product Information. Available at: https://www.ebs.tga.gov.au/ebs/picmi/pic... Accessed: November 2014

3. ILAE/IBE/WHO, Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe 2010. Available at; http://www.ilae.org/Visitors/Documents/ILAEAnnual-Report2010... Accessed: October 2014

4. Epilepsy Action Australia. Facts and statistics about Epilepsy. Available at: http://www.epilepsy.org.au/resources/for-media/facts-statist... Accessed: October 2014

5. Fycompa Product Information. Available at: https://www.ebs.tga.gov.au/ebs/picmi/pic... Accessed: November 2014

6. World Health Organisation. Atlas of Health in Europe. 2003. World Health Organization, Regional Office of Europe, Copenhagen, Denmark.

7. Cancer Research UK. Breast cancer incidence statistics. Available at: http://www.cancerresearchuk.org/cancer-info/cancerstats/type.... Accessed: September 2014

8. Epilepsy in the WHO European Region: Fostering Epilepsy Care in Europe. http://www.ibe-epilepsy.org/downloads/EURO%20Report%20160510... Accessed: September 2014

9. Pugliatti M et al. Estimating the cost of epilepsy in Europe: A review with economic modeling. Epilepsia 2007:48(12):2224-2233.


Date of preparation: November 2014
Job code: Corporate-UK2029

CONTACT: Media Enquiries: Eisai Europe Ltd: Cressida Robson / Ben Speller,+44(0)7908-314-155 / +44(0)7908-409416, Cressida_Robson@eisai.net /Ben_Speller@eisai.net. Tonic Life Communications: Ainsley Cooper / NicolaLilley, +44-(0)20-7798-9907 / +44-(0)207-798-9905,Ainsley.Cooper@toniclc.com / Nicola.Lilley@toniclc.com

Comunicados

Si quieres mejorar el posicionamiento online de tu marca, ahora puedes publicar tus notas de prensa o comunicados de empresa en la sección de Comunicados de europa press

Si necesitas asesoramiento en comunicación, redacción de tus notas de prensa o ampliar la difusión de tu comunicado más allá de la página web de europa press, ponte en contacto con nosotros en comunicacion@europapress.es o en el teléfono 913592600